Boesen Biotech ApS: Financial statements 2021
CVR: 39142635
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Boesen Biotech ApS (CVR 39142635) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -33,549 and a net result of DKK 8,080,859 compared with DKK 2,309,304 the year before. Equity in the 2021 report amounted to DKK 10,163,289. The solvency ratio was 62.6%.
- Gross Profit
- DKK -33,549
- Profit/Loss
- DKK 8,080,859
- Equity
- DKK 10,163,289
- Total Assets
- DKK 16,233,416
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -34K | 8.1M | 10.2M | - |
| 2020 | - | -21K | 2.3M | 2.1M | - |
| 2019 | - | -14K | -2K | -227K | - |
| 2018 | - | -20K | -536K | -225K | - |
| 2017 | - | -19K | 261K | 311K | - |
Official annual report
Find more companies like Boesen Biotech ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
Boesen Biotech ApS has published its annual report for 2020. Gross profit came to DKK -21,205, and the net result was DKK 2,309,304.
About Boesen Biotech ApS
Boesen Biotech ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Thomas Boesen. The company is owned by T. BOESEN HOLDING ApS and Gudter ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -54,998 and a net result of DKK 2,039,886 compared with DKK 723,812 the year before. Equity in the 2025 report amounted to DKK 3,496,600.